Parkinson’s disease Ziekte van Parkinson
Conditions
Interventions
The experimental group will receive therapy in which mental practice is routinely used with the physical therapy given. Embedded MP will be used.
The control group will receive therapy as usual in ac
Sponsors
Research Centre for Autonomy and Participation
Eligibility
Inclusion criteria
Inclusion criteria: 1. Clinically diagnosed adult patients with Parkinson’s disease; 2. Sufficient cognitive level and communication skills to engage in mental practice; this is a clinical judgement. Hoehn and Yahr classification: 1-3.
Exclusion criteria
Exclusion criteria: Severe additional impairments prior to disease onset.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To measure if MP improves the performance of activities in the experimental group more than in the control group an 11-point numerical rating scale will be used: 11 point Numerical rating scale assesses changes in the performance of the activity ‘walking’ ranging from 10 (‘excellent’) to 0 (‘poor’) as perceived by the patient and the therapist. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Timed up and go (TUG - activity level); 2. 10 meter walking test (TML - activity level). | — |
Contacts
Public ContactSusy Braun
Centre of Expertise in Life Sciences, Kenniskring Autonomie & Participatie, Fac. Gezondheid & Techniek, HsZuyd
Outcome results
None listed